The company was established in North America in United States. The main department of described Corporate Investor is located in the Ada.
The typical case for the fund is to invest in rounds with 1 participant. In the next rounds fund is usually obtained by Bay City Capital, New Enterprise Associates, Delta Dental.
Among the various public portfolio startups of the fund, we may underline Interleukin Genetics We can highlight the next thriving fund investment areas, such as Health Care, Medical. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The higher amount of exits for fund were in 2003. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2006.
Fund Name | Location |
agRIF | - |
Alexandria LaunchLabs | New York, New York, United States |
Beijing Rongjin Borui Touzi Zixun Youxian Gongsi | Beijing, China, Tongzhou |
Besunyen (Beijing Outsell Health) | China, Guangdong, Wanchai |
Cogepa | France, Ile-de-France, Paris |
Dai-Dan | Japan, Osaka, Osaka Prefecture |
Dayli Partners | Seoul, Seoul-t'ukpyolsi, South Korea |
Dinglong Culture | - |
Eight Roads Ventures Japan | Japan, Tokyo |
ESRG Investments | - |
FD Mediagroep | - |
GENIUS NY | New York, Syracuse, United States |
Heyihui Capital | Beijing, Beijing, China |
KNOXX | Kansas, United States, Wichita |
LAB Miami Ventures | Florida, Miami, United States |
Rage Capital | - |
Serica Partners | - |
Shunying Capital | China, Guangdong, Zhuhai |
Susquehanna International Group (SIG) | Bala Cynwyd, Pennsylvania, United States |
VDP Croissance | - |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.